Sodium-Glucose Cotransporter-2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report
•This study highlighted a rare postoperative complication after heart transplantation.•We emphasized the challenges of perioperative management for heart transplantation.•The findings encouraged careful use of sodium-glucose cotransporter-2 inhibitors for patients awaiting heart transplantation. Pos...
Saved in:
Published in: | Transplantation proceedings Vol. 53; no. 8; pp. 2636 - 2639 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-10-2021
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •This study highlighted a rare postoperative complication after heart transplantation.•We emphasized the challenges of perioperative management for heart transplantation.•The findings encouraged careful use of sodium-glucose cotransporter-2 inhibitors for patients awaiting heart transplantation.
Postoperative euglycemic diabetic ketoacidosis (euDKA) associated with sodium-glucose cotransporter-2 (SGLT2) inhibitor use has been well-documented and carries a Food and Drug Administration recommendation to hold SGLT2 inhibitors 3 to 4 days before a planned surgical procedure. Unfortunately, many surgical procedures, such as orthotopic heart transplant (OHT), are unplanned and unpredictable. With the increasing use of SGLT2 inhibitors in diabetic and non-diabetic heart failure patients, new challenges in patient management and perioperative risk have arisen. We report a case in which SGLT2 inhibitor–associated euDKA complicated the postoperative course of a prediabetic patient who had undergone OHT. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0041-1345 1873-2623 |
DOI: | 10.1016/j.transproceed.2021.08.017 |